Seven Fleet Capital Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Seven Fleet Capital Management's DFTX Position: Q3 2026 in Review
Seven Fleet Capital Management reduced its Definium Therapeutics (DFTX) stake by 27% in Q3 2026, selling an estimated $1.69M and leaving 108,647 shares worth $4.14M. The position accounts for 0.81% of the portfolio, ranked #22.
Seven Fleet Capital Management first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.99M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Seven Fleet Capital Management held 108,647 shares of Definium Therapeutics worth $4.14M as of Q3 2026.
- Seven Fleet Capital Management sold 40,000 Definium Therapeutics shares in Q3 2026, an estimated $1.69M.
- Definium Therapeutics made up 0.81% of Seven Fleet Capital Management's portfolio in Q3 2026, its #22 holding.
- Seven Fleet Capital Management first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Seven Fleet Capital Management's Definium Therapeutics position peaked at $6.99M in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Seven Fleet Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.